recombinant adenovirus containing the ornithine transcarbamylase gene
Gene therapyexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 1995 (NCT00004386)
Timeline
1990s
- Jan 1, 1995
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Ornithine carbamoyltransferaseSupplementation
OTC supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- recombinant adenovirus containing the ornithine transcarbamylase gene
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00004386 | Phase 1 | Oct 1, 1995 | Children's National Medical Center, National Institutes of Health (NIH) |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Children's National Medical Center | Academic/Hospital | 1 | 0 | 1 | 1995 |
| National Institutes of Health (NIH) | Government | 1 | 1 | 1 | 1995 |
2 organizations
Page 1 / 1